Clinical Trial Protocol Registry and Library

Design, Analyze, Communicate: Working together to improve clinical study outcomes.

Focusing on research Protocols where the trial sites were located in low- and middle-income countries, this resource includes three ways to access the Protocol Library:

  1. A table of all of the clinical trial protocols included in the Protocol Library
  2. A downloadable Excel registry list of all the clinical trial protocols included in the Protocol Library
  3. The Protocol Library sorted into disease area folders to allow direct access to relevant protocols

Clinical Trial Protocol Registry Table

Use this table to filter the Protocol Library to access specific protocols.

Filter the resources using the dropdown menus. Select a column heading to sort. Click or tap on a row to view the full record

First Principal Investigator Protocol Title Disease/Disease Area Region of Study
Tinto, Halidou Extension to study MALARIA-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa

Link to Protocol

First Principal InvestigatorTinto, Halidou

Disease/Disease AreaMalaria

Site CountriesTanzania, Kenya, Burkina Faso

Source of Protocolclinicaltrials.gov

Approximate Page Count98

Date of Scientific Journal Publication8/19/2019

Scientific Journal Publicationhttps://pubmed.ncbi.nlm.nih.gov/31300331/

Malaria Africa

Downloadable Clinical Trial Protocol Registry

Download the Clinical Trial Protocol Registry to access a detailed Excel spreadsheet of all the publicly available global health protocols included in the Protocol Library and the links to access them.

Protocol Library

The Protocol Library includes publicly available global health trial protocols (sorted into disease area folders).

Human Immunodeficiency Virus

Neglected Tropical Diseases

Tuberculosis

Malaria

Maternal, Newborn, & Child Health

Nutrition

Vaccines

Enteric & Diarrheal Diseases

Pneumonia

Polio

Women's Health Innovations

Please note: Implementors of studies should also always refer to relevant regulatory standards and guidelines (e.g. FDA, EMA) to assist with study/protocol design.